Accinov’s business model relies on a new 70,000-ft² (6,500-m²) building designed to meet the high-end requirements of clinical material development and manufacturing. Access to the infrastructure is provided as part of a broader service offering that includes GMP facility management and pharmaceutical support and expertise. Qualified persons and quality-assurance services ensure compliance of activities performed by clients with GMP regulations and the Accinov quality management system.
Our quality and pharmaceutical services are responsible for releasing raw materials and drug batches as well as qualifying suppliers and auditing third parties. That allows client companies to focus on their own core bioprocess and analytical activities.
Accinov staff members are also dedicated to site management, including technical maintenance and coordination of services such as site security, cleaning, and deliveries. Hosted companies dedicate their own staff to strategic activities without the constraints of fully operating a GMP site on their own.
The facility design and the site management ensure confidential control of intellectual property (IP) and know-how without risk of cross-contamination.